NCT01491984

Brief Summary

A laryngoscope is a medical instrument that is used to get a view of the voice box and the space in between the vocal cords. A laryngoscope is used to place a breathing tube into the trachea (windpipe or airway) to protect the patient's airway and provide a way to help a person breathe during surgery; this is called intubation.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jul 2009

Shorter than P25 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

December 12, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 14, 2011

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

March 10, 2015

Completed
Last Updated

March 10, 2015

Status Verified

February 1, 2015

Enrollment Period

1 year

First QC Date

December 12, 2011

Results QC Date

May 22, 2013

Last Update Submit

February 24, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cormack-Lehane Grade

    The anesthesiologist graded the laryngeal view after induction of anesthesia using Cormack-Lehane Scale. Grade 1 = full view of glottis Grade 2a = partial view of glottis Grade 2b = Only posterior extremity of glottis seen or only arytenoid cartilages Grade 3 = Only epiglottis seen, none of glottis seen Grade 4 = Neither glottis nor epiglottis seen

    intraoperative

Secondary Outcomes (3)

  • Number of Intubation Attempts

    intraoperative

  • Operator Rating of Difficulty

    intraoperative

  • Time to Successful Intubation

    intraoperative

Study Arms (2)

Laryngoscopy order: 1) MAC, 2) Levitan

EXPERIMENTAL

Levitan FPS Intubation

Device: Laryngoscopy order: 1) MAC, 2) LevitanDevice: Laryngoscopy order: 1) Levitan, 2) MAC

Laryngoscopy order: 1) Levitan, 2) MAC

EXPERIMENTAL

Macintosh Intubation

Device: Laryngoscopy order: 1) MAC, 2) LevitanDevice: Laryngoscopy order: 1) Levitan, 2) MAC

Interventions

Laryngoscopy with MAC, then Levitan

Laryngoscopy order: 1) Levitan, 2) MACLaryngoscopy order: 1) MAC, 2) Levitan

Laryngoscopy with Levitan, then MAC

Laryngoscopy order: 1) Levitan, 2) MACLaryngoscopy order: 1) MAC, 2) Levitan

Eligibility Criteria

Age16 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I or II (healthy or mild systemic disease, ex. asthma, high blood pressure)
  • Elective surgery requiring endotracheal intubation
  • English speaking
  • Age 16 - 75 years

You may not qualify if:

  • Significant gastroesophageal reflux disease (GERD) that may require alternate induction/intubation techniques
  • Prior history of a difficult intubation requiring an awake tracheal intubation
  • Clinical predictors of a potentially difficult intubation requiring an awake intubation
  • BMI \> 45 kg/m2 (Obesity is a common and important risk factor for difficult intubation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Results Point of Contact

Title
Dr. Ronald George
Organization
IWK Health Centre

Study Officials

  • Ronald B George, MD

    IWK Health Centre

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Investigator, MD, FRCPC, Assistant Professor

Study Record Dates

First Submitted

December 12, 2011

First Posted

December 14, 2011

Study Start

July 1, 2009

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

March 10, 2015

Results First Posted

March 10, 2015

Record last verified: 2015-02